HLHans-Anton Lehr

Hans-Anton Lehr

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Hans-Anton Lehr has a total of 23 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Atherosklerose - Progression durch unspezifische Aktivierung des Immunsystems

    by Hans-Anton Lehr, Tolga Atilla Sagban, C. James Kirkpatrick

    Die Atherosklerose ist eine Erkrankung mittelgroßer und großer Gefäße. Frühläsionen sind gekennzeichnet durch die Adhäsion und subendotheliale Emigration zirkulierender Monozyten, die als Schaumzellen Wegbereiterfunktionen für spätere komplexe Plaques übernehmen. Solche Läsionen sind bereits im Kindes- und Jugendalter zu finden. Der nächste Schritt der Atherogenese ist die Proliferation glattmuskulärer Zellen innerhalb der Intima und der Media und damit ein gradueller Verschluss des Gefäßlumens. Fibroblastäre Zellen tragen ferner zum Läsionswachstum bei, indem sie exzessive Mengen extrazellulärer Matrix bilden. Derartige Läsionen sind meist klinisch inapparent. In einer nächsten Phase kommt es zur Degeneration der Läsion, zur Ausbildung zentral nekrotischer Lipidseen aus Cholesterylkristallen. Entzündungszellen sowie Zelltrümmern. Eine fibröse Kappe trennt den Lipidsee von zirkulierendem Blut und verhindert die Ahäsion und Aggregation von Blutplättchen an dem hochproaggregatorischen Lipidmaterial. Nur wenn diese Kappe im Bereich der Schulter einreißt, kommt es zur raschen Ausbildung eines Apositions- oder (im Koronarsystem oft) eines Okklusionsthrombus mit der entsprechend dramatischen klinischen Symptomatik. Die wissenschaftliche Auseinandersetzung mit der Atherosklerose wird bestimmt durch ihre Chronizität sowie das Unvermögen von Tiermodellen, den Pathomechanismus hinreichend zu simulieren. Unser heutiges Wissen und unsere wissenschaftliche Auseinandersetzung mit dem Thema sind bestimmt durch die “response to injury”– Hypothese von Russell Ross. Die Rolle modifizierter Low-Density-Lipoproteine wird ebenso kritisch diskutiert wie die des Immunsystems infektiöser Mechanismen, sowie auch von Erbfaktoren. Ungeachtet des exakten Pathomechanismus sind die Risikofaktoren heute etabliert (Hypercholersterinämie, Bluthochdruck, Diabetes, Zigarettenrauchen etc.), ebenso wie effektive präventive Interventionen (Lifestyle-Veränderungen, vermehrte körperliche Betätigung, “gesunde” Diät sowie pharmakologische Interventionen bei Diabetes, Bluthochdruck, Hyperlipidämie). Unser heutiges Verständnis der Atherosklerose als komplexes, chronisches Geschehen hat nichts mehr zu tun mit derm archaischen Konzept der degenerativen Gefäßerkrankung. Das neue pathomechanistische Konzept nimmt uns als Patienten wie als Ärzte in die Verantwortung – ob wir dies wollen oder nicht. Der rauchende, übergewichtige Arzt passt nicht mehr in unsere moderne medizinische Landschaft. Atherogenesis is a disease of middle-sized and large-caliber blood vessels that can be divided into three major phases. The initial lesions of early atherosclerosis are characterized by the adhesion and subendothelial emigration of blooe-borne monocytes, which differentiate into macrophates and provide the morphologic basis for the formation of foam cells and fatty streak lesions. These lesions are found in most children and teenagers in industrialized nations. The next key event in atherogenesis is the proliferation of smooth muscle cells within the intima and media, resulting in the gradual compromise of the vessel lumen. Myofibroblastic cells also contribute to lesion growth through the production of excessive amounts of extracellular matrix. Such lesions are clinically silent unless progression to the next phase continues: the lesions degenerate, forming a mostly necrotic “lipid core” consisting of extracellular lipid, cholesterol crystals, inflammatory cells and necrotic debris. A fibrous cap is formed which prevents the interaction of blood cells, particularly of platelets with the highly proaggregatory material found in the lipid core. However, continuous inflammatory activity and/or heightened mechanical stress (i. e. in hypertension) tends to weaken the fibrous caps. Eventually, plaque rupture ensues, platelets aggregate, and the lesions become clinically manifest in such dramatic events as myocardial infarction, stroke, or mesenteric ischemia. Research into lesion formation and progression is limited by the fact that lesions devleop in silence over many decades and that animal models only incompleteley model the situation in humans. Most currently debated concepts accept the “response to injury” hypothesis formulated by the late Russell Ross and the multi-factorial nature of atherogenesis. The discussion today circles around the relative contributions of low density lipoproteins (oxidized or enzymatically modified LDL?), the immune response (adaptive or innate?), infectious agents (CMV, Chlamydia pneumoniae?), and/or hereditary factors, to name only a few of the most widely debated concepts. Irrespective of the outcome of this pathomechanistic discussion, the knowledge of established risk factors (hypercholesterolemia, hypertension, diabetes, smoking, etc.) and protective interventions (lifestyle changes, physical exercise, “healthy” diets, effective dietary and pharmacologic control of hyperglycemia, blood pressure or hyperlipidemia) has helped to define atherosclerosis as a “new entity” that has little to do with the archaic concept of a “degenerative” vessel disease. The new concept takes us into the responsibility – puts us in charge of our own and our patients' cardiovascular risk – whether we like it or not. The smoking obese doctor no longer fits into the modern medical landscape.


  • Particulate Matter Contamination of Intravenous Antibiotics Aggravates Loss of Functional Capillary Density in Postischemic Striated Muscle

    by Hans-Anton Lehr, Joachim Brunner, Ramzan Rangoonwala, C. James Kirkpatrick

    Through the increased use of less expensive and counterfeit medicines, the contamination of parenteral fluids and drugs by particulate matter poses an increasing health hazard worldwide. However, the mechanism of action of such contamination has never been conclusively demonstrated. We have systemically injected the particles contained in three different 1-g preparations of the antibiotic cefotaxime into hamsters and visualized the functional capillary density in striated skin muscle, using intravital fluorescence microscopy. Injection of particles from either of the three preparations did not affect capillary perfusion in normal muscle (n = 3 hamsters, each). However, injection of particles from two generic drug preparations, but not the original preparation or the saline control, significantly reduced capillary perfusion in muscle tissue that had previously been exposed to 4 h of pressure-induced ischemia and 2 h of reperfusion (n = 9 hamsters per group). Histological sections demonstrated birefringent particles mechanically obliterating the microcirculation of the striated muscle. The loss of capillary perfusion due to particle injection or injection of standardized microspheres was dependent on the extent of ischemia/reperfusion-induced muscle injury, with more capillaries lost in the more severely compromised muscle areas. These findings suggest that particle contaminants may not pose a major threat in intact tissue, but may severely compromise tissue perfusion in patients with prior microvascular compromise of vital organs (i.e., after trauma, major surgery, or sepsis) and thus predispose to complications such as acute respiratory distress syndrome or multiple organ failure.


    • 1 January 2001
      • Vol. 85, 132-41

    [Atherosclerosis--search for a new entity].

    by H A Lehr, C J Kirkpatrick

    Atherogenesis is a disease of middle-sized and large caliber blood vessels that can be divided into three major phases. The initial lesions of early atherosclerosis are characterized by the adhesion and subendothelial emigration of blood-borne monocytes, which differentiate into macrophages and provide the morphological basis for the formation of foam cells and fatty streak lesions. These lesions are found in most children and teenagers in industrialized nations. The next key event in atherogenesis is the proliferation of smooth muscle cells within the intima and media, resulting in the gradual compromise of the vessel lumen. Myofibroblastic cells also contribute to lesion growth through the production of excessive amounts of extracellular matrix. Such lesions are clinically silent unless progression to the next phase continues: the lesions degenerate, forming a mostly necrotic "lipid core" consisting of extracellular lipid, cholesterol crystals, inflammatory cells and necrotic debris. A fibrous cap is formed which prevents the interaction of blood cells, particularly of platelets with the highly proaggregatory material found in the lipid core. However, continuous inflammatory activity and/or heightened mechanical stress (i.e. in hypertension) tends to weaken the fibrous caps. Eventually, plaque rupture ensues, platelets aggregate, and the lesions become clinically manifest in such dramatic events as myocardial infarction, stroke, or mesenteric ischemia. Research into lesion formation and progression is limited by the fact that lesions develop in silence over many decades and that animal models only incompletely model the situation in humans. Most currently debated concepts accept the "response to injury" hypothesis formulated by the late Russell Ross and the multifactorial nature of atherogenesis. The discussion today circles around the relative contributions of low density lipoproteins (oxidized or enzymatically modified LDL?), the immune response (adaptive or innate?), infectious agents (CMV, chlamydia pneumoniae?), and/or hereditary factors, to name only a few of the most widely debated concepts. Irrespective of the outcome of this pathomechanistic discussion, the knowledge of established risk factors (hypercholesterolemia, hypertension, diabetes, smoking, etc.) and protective interventions (lifestyle changes, physical exercise, "healthy" diets, effective dietary and pharmacological control of hyperglycemia, blood pressure or hyperlipidemia) has helped to define atherosclerosis as a "new entity" that has little to do with the archaic concept of a "degenerative" vessel disease.


    • 1 December 2000
      • Vol. 7, 367-84

    Microcirculatory dysfunction induced by cigarette smoking.

    by H A Lehr

    This review deals with the deleterious effects of cigarette smroking on the microcirculation, both in terms of morphological (i.e., vessel wall injury, capillary loss) and functional aspects. The latter concerns predominantly changes in tissue perfusion and its regullatory mechanisms (i.e., reactive hyperemia, sequestration of blood cells in the microcirculation). The mechanisms of action of cigarette smoking on the microcirculation include compromised endothelial-dependent voasorelaxation, platelet aggregation, emdothelial cell dysfunction and the activation of circulating leukocytes. Through these mechanisms, cigarette smoking elicits the aggregation and adhesion of leukocytes and/or platelets to the microvascular endothelium in venules and arterioles, as assessed by intravital fluorescence microscopy in the hamster skinfold chamber model. This model has allowed us to learn more about the participation of reactive oxygen species, inflammatory mediators, and adhesion molecules in the orchestration of microcirculatory dysfunction after cigarette smoking. In the final part of this review, the clinical consequences of microcirculatory dysfunction are discussed and an outlook is offered on potential prophylactic interventions (i.e., antioxidant vitamins) aimed at abrogating the deleterious action of cigarette smoking on the microcirculation.


  • Endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet

    by H.A. Lehr, T.A. Sagban, U. Zähringer, K.P. Hungerer, M. Blumrich, S. Bhakdi

    • 1 September 1994
      • Vol. 71  (3) , 380-6

    P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo.

    by H A Lehr, A M Olofsson, T E Carew, P Vajkoczy, U H Von Andrian, C Hübner, M C Berndt, D Steinberg, K Messmer, K E Arfors

    Oxidized low density lipoprotein (oxLDL) has been demonstrated to stimulate leukocyte/endothelium interaction, an early feature of atherogenesis. Using the skinfold chamber model for intravital microscopy in hamsters and mice, we have shown that oxLDL-induced leukocyte adhesion to microvascular endothelium shares many characteristics with leukocyte adhesion during inflammation and ischemia/reperfusion, including the involvement of beta 2 integrin adhesion molecules. In light of the two-step model of leukocyte adhesion, we have examined the contribution of P-selectin to oxLDL-induced leukocyte/endothelium interaction. P-selectin is an inducible adhesion molecule on platelets and endothelium, mediating the initial steps of leukocyte margination and rolling along the endothelial lining, as well as of aggregate formation between platelets and leukocytes. For our studies, we used the dorsal skinfold chamber model for intravital fluorescence microscopy on awake Syrian golden hamsters. Hamsters were treated 10 minutes before oxLDL-injection (oxidized by Cu2+, 4 mg/kg body weight, intravenously) with blocking antibodies to P-selectin (2 mg/kg body weight intravenously, N = 7). In seven control animals (pretreated with an irrelevant IgG antibody), oxLDL injection elicited leukocyte rolling and adhesion on both venular and arteriolar endothelium, and also the formation of aggregates tumbling down the microvessels and firmly adhering to the microvascular endothelium. The aggregates consisted of leukocytes and activated, dendritic platelets, as assessed by scanning electron microscopy of the buffy coat isolated by density gradient centrifugation of whole blood taken from hamsters 15 minutes after injection of oxLDL. Leukocyte adhesion to venular and arteriolar endothelium, as well as the formation of leukocyte/platelet aggregates were significantly reduced by pretreatment of the animals with anti-P-selectin antibodies. These data emphasize the similarities between leukocyte adhesion in response to oxLDL and in other pathophysiologic conditions, identifying P-selectin as a crucial player in the interaction between leukocytes and microvascular endothelium as well as in the formation of circulating leukocyte/platelet aggregates.


    • 1 January 1994
      • Vol. 1  (1) , 92-9

    Mechanisms of tissue damage by leukocytes.

    by H A Lehr, K E Arfors

    Leukocyte adhesion and emigration are involved in host defense and phagocytosis and thus serve a beneficial role during the mounting of a well-contained inflammatory response. However, in certain situations, leukocytes may turn against the host and contribute to tissue damage and organ dysfunction. While trying to summarize the current opinion about the mechanisms by which leukocytes contribute to tissue damage, one finds that leukocyte-inflicted tissue damage involves a network of marked complexity, requiring an orchestrated crosstalk between different cell types, mediators, cytotoxic agents, and their respective inhibitors. Now that an abundance of information is available as to where, when, and how leukocytes contribute to tissue damage, one of the key questions remains unsolved: is leukocyte-inflicted tissue damage true damage, or is it rather a crucial step in tissue repair, healing, and scar formation? Future research will have to address this question, thoroughly differentiating between the role of leukocytes in diverse pathophysiological situations, ranging from cigarette smoke-induced pulmonary emphysema and immune-triggered transplant rejection to myocardial and cerebral infarction. Knowledge of how leukocytes damage tissue only shows us the tools; knowledge of why will provide us with the basis for effective therapeutic interventions.


  • Impact of Ischemia on Tissue Oxygenation and Wound Healing: Improvement by Vasoactive Medication

    by M. Kamler, H. A. Lehr, R. K. Saetzler, T. J. Galla, K. Messmer

    Wound healing is a complicated process, accomplished by a variety of interrelated metabolic pathways. Disturbances of any of these aspects will result in impaired wound healing. Besides generalized diseases like diabetes mellitus and immunodeficiencies, systemic or local infections can jeopardize tpe normal wound healing process. Finally, chronic ischemia due to inadequate tissue perfusion and oxygenation can have protracting or deletary effects on the process of wound healing. Inadequate tissue oxygenation results from a discrepancy between oxygen demand and oxygen supply to the impaired tissue. These pathologic conditions include both acute states of ischemia following trauma as well as chronic ischemia in peripheral arterial disease and chronic venous insufficiency. A variety of therapeutic interventions are used to improve the perfusion and oxygenation of the endangered tissue. Elimination of risk factors like cigarette smoking and hypercholesteremia, physical exercise, surgical interventions (bypass, sympathectomy etc.) and finally pharmacological approaches have been studied, with the aim to achieve increased tissue perfusion and improvement of the rheological properties of the blood. Keywords Wound Healing Hairless Mouse Chronic Ischemia Chronic Venous Insufficiency Vasoactive Medication These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.